The Technical Analyst
Select Language :
Till Capital Ltd. [TIL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Till Capital Ltd. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Till Capital Ltd. is listed at the  Exchange

-1.82% $10.80

America/New_York / 28 mar 2024 @ 16:00


Till Capital Ltd.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 70.24 mill
EPS: -24.00
P/E: -0.450
Earnings Date: May 09, 2024
SharesOutstanding: 6.50 mill
Avg Daily Volume: 0.0321 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.450 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.08x
Company: PE -0.450 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 10.30 - 11.30

( +/- 4.63%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-10 Laumas Sandeep Buy 80 000 Employee Stock Option (right to buy)
2024-02-10 Crouch Bronson Buy 120 000 Employee Stock Option (right to buy)
2023-06-14 Binder Gwendolyn Buy 1 500 Stock Option (Right to Buy)
2023-06-14 Mcgaughy R Kent Jr Buy 1 500 Stock Option (Right to Buy)
2023-06-14 Gibson Neil W Buy 1 500 Stock Option (Right to Buy)
INSIDER POWER
94.50
Last 92 transactions
Buy: 125 955 560 | Sell: 140 779 900

Forecast: 16:00 - $11.00

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $11.00
Forecast 2: 16:00 - $11.00
Forecast 3: 16:00 - $11.00
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $10.80 (-1.82% )
Volume 0.0130 mill
Avg. Vol. 0.0321 mill
% of Avg. Vol 40.56 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Till Capital Ltd.

Last 12 Months

Last 12 months chart data with high, low, open and close for Till Capital Ltd.

RSI

Last 10 Buy & Sell Signals For TIL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Till Capital Ltd.

TIL

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Last 10 Buy Signals

Date Signal @
KUBUSDMar 28 - 19:082.69
FISUSDMar 28 - 19:030.952
PROPCUSDMar 28 - 18:585.09
XCADUSDMar 28 - 18:571.490
INDEXUSDMar 28 - 18:565.95
FUMOUSDMar 28 - 18:5410 001
ALPHUSDMar 28 - 18:542.71
HNTUSDMar 28 - 18:47$6.19
WBTUSDMar 28 - 18:438.37
TRXUSDMar 28 - 18:39$0.120

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.